Dr. Evelyn Rankin is a speech language pathologist practicing in MIDDLEBORO, MA. Dr. Rankin specializes in speech, language and swallowing disorders in patients. As a speech language pathologist, Dr. Rankin evaluates, diagnoses and treats patients with communication and swallowing troubles. These conditions may be due to developmental delay, brain injury, hearing loss, autism, stroke or other diseases and injuries. Dr. Rankin helps patients make sounds and improve their voices through various methods. Speech language pathologists also work with patients to strengthen muscles used to speak and swallow, and work with individuals and families to help cope with their conditions.
- Clinical and endoscopic features of melanoma metastases in the upper GI tract.
- Modern treatment of ovarian cancer.
- Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer.
- Acute interstitial nephritis during continuous intravenous administration of low-dose interleukin-2.
- Weekly cisplatin with oral etoposide: a well-tolerated and highly effective regimen in relapsed ovarian cancer.
- First-into-man phase I and pharmacokinetic study of XR5944.14, a novel agent with a unique mechanism of action.
- Epirubicin at two dose levels with prednisolone as treatment for advanced breast cancer: the results of a randomized trial.
- Metastatic vipoma arising from colonic primary tumour.
- Hypersensitivity reaction to epirubicin.
- Back pain and testicular germ cell tumours.
- Persistent back pain due to malignant lymphadenopathy.
- Low back pain and cancer.
- Phase II trial of prednimustine as first-line chemotherapy in patients with advanced breast cancer.
- A phase II study of 4-deoxydoxorubicin in advanced breast cancer.
- Phase I and pharmacokinetic study of flavone acetic acid.
- A mathematical model of the development of drug resistance to cancer chemotherapy.
- A phase II study of ifosfamide in advanced and relapsed carcinoma of the cervix.
- Treatment of two patients with B cell lymphoma with monoclonal anti-idiotype antibodies.
- Radioimmunodetection of cancer: problems and potential.
- Observations on the toxicity of the combination of gentamicin and mezlocillin in the treatment of patients with acute leukaemia.
- Mouse monoclonal antibodies against the idiotype of human B cell non-Hodgkin lymphomas: production, characterization and use to monitor the progress of disease.
- Dynamic studies of lymphocytes labelled with indium-111 during and after treatment with monoclonal anti-idiotype antibody in advanced B cell lymphoma.
- Intermediate dose single agent cyclophosphamide chemotherapy of advanced breast cancer.
- Shared idiotypes among surface immunoglobulins in non-Hodgkin's lymphoma.
- Pneumocystis carinii pneumonia: a light microscopical and ultrastructural study.
- Staging patients with non-Hodgkin's lymphoma.
- Treatment of low-grade non-Hodgkin's lymphoma with continuous infusion of low-dose recombinant interleukin-2 in combination with the B-cell-specific monoclonal antibody CLB-CD19.
- Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.
- Scientific aspects of gene therapy in melanoma.
- Report of a symposium on: diagnosis and treatment of cutaneous head and neck melanoma.
- Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide.
- Recombinant interleukin-2 in cancer: basic and clinical aspects.
- Catheter-related complications in 52 patients treated with continuous infusion of low dose recombinant interleukin-2 via an implanted central venous catheter.
- Phase II study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer.
- Reconstitution of recombinant interleukin-2 (rIL-2): a comparative study of various rIL-2 muteins.
- A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part II: Immunological aspects.
- Possible role for cytotoxic lymphocytes in the pathogenesis of acute interstitial nephritis after recombinant interleukin-2 treatment for renal cell cancer.
- Ophthalmic toxicity during carboplatin therapy.
- IL-1 beta does not cause neutrophil degranulation but does lead to IL-6, IL-8, and nitrite/nitrate release when used in patients with cancer.
- Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group.
- Detection of early micrometastases in malignant melanoma.
- The luminescence immunoassay S-100: a sensitive test to measure circulating S-100B: its prognostic value in malignant melanoma.
Mrs. Evelyn Mae Rankin M.S.CCC-SLP's Practice location
MIDDLEBORO, MA 02346Get Direction
Mrs. Evelyn Mae Rankin M.S.CCC-SLP's reviewsWrite Review
- Is There a Cure for Autism?
It is natural to ask your doctor about the cure for any disease once you have been diagnosed with it. The same is true for those diagnosed with autism. Unfortunately, there is no cure for autism.Various behavioral adjustment methods and medications that manage autism’s core symptoms are available...
- Raising a Child with Autism
Autism spectrum disorder (ASD), or autism, is a term used to describe a group of complex brain disorders in human beings. These disorders affect the social interaction of a person, verbal skills, nonverbal communication, and repetitive behaviors, along with any activity that needs a person to react...
- The Risk for Developing Cerebral Palsy in Babies is Higher at 37 or 38 Weeks
Babies born at 40 weeks have a lower risk of developing cerebral palsy, when compared to babies born at 37 or 38 weeks, or at 42 weeks and later, according to a new study published in, The Journal of the American Medical Association. But the absolute risk of developing this condition in babies is...
- What Is Dysphagia?
IntroductionDysphagia is the medical term for difficulty swallowing. A person with dysphagia finds it more difficult to move liquid or food from the mouth to the stomach. Dysphagia is most likely caused by muscle and nerve problems. When food is swallowed, multiple muscles and nerves are...
- What Is Lou Gehrig's Disease?
IntroductionLou Gehrig's disease is a neurodegenerative disorder that affects the brain and spinal cord. It is also called as amyotrophic lateral sclerosis or ALS. It is a progressive disorder that leads to the loss of voluntary muscle control in the body. This disorder often affects the...
- Everything You Need To Know About Multiple Sclerosis
CausesMS is the result of an abnormal response of the body’s immune system. This response results in an attack on the central nervous system — the brain, spinal cord and optic nerve. Specifically the immune system attacks the protective coating around the nerve fibers — myelin — creating...
- Robyn F Dragonetti MS CCC-SLP23 ISAAC ST MIDDLEBORO MA 02346
- Lauretta Place234 W CENTER ST WEST BRIDGEWATER MA 02379
- Mrs. Patricia A. Abdelal M.S., CCC27 HUNTINGTON RD PLYMOUTH MA 02360
- Mrs. Rosemary Frances Miller M.S.,CCC/SLP4586 ACUSHNET AVE NEW BEDFORD MA 02745
- Ali Seiderman1115 W CHESTNUT ST BROCKTON MA 02301
- Mrs. Amy J. Blanchette M.S.37 Belmont St Brockton MA 02301